News
Pfizer/BioNTech shot may beat new virus mutation, study finds
The Pfizer/BioNTech vaccine appears to work against an important …
21028 items found
News
EMA will use Panalgo software for real-world data analytics
Six months after rebranding from BHE, Panalgo has won a contract to …
News
Angelini and Arvelle create neurology player with $960m merger
There’s a new player in the neurology and mental health drugs market …
News
Unconvinced by NHS test run, NICE rejects BMS' Opdivo in head and neck cancer
NICE has rejected Bristol Myers Squibb’s immunotherapy Opdivo as a …
News
Moderna’s COVID-19 vaccine is third approved in UK
The UK has approved the Moderna coronavirus vaccine, hard on the …
News
AmerisourceBergen buys Walgreens Boots Alliance wholesaling business for $6.5bn
US wholesale giant AmerisourceBergen is to buy the majority of …
News
Bioclinica boosts digital trial credentials with Saliency buy
With the ink barely dry on its last merger agreement, clinical trial …
News
Sanofi buys UK's Kymab and inflammatory disease hopeful for $1.45bn
Sanofi is to acquire UK biotech Kymab in a deal worth up to $1.45 …
News
Chi-Med agrees R&D partnership with Inmagene
China’s Chi-Med and Inmagene Biopharmaceuticals have agreed a …
Views & Analysis
2021 Outlook: The future for life sciences customer experience
Research from a large-scale survey of 1000+ senior pharma …
News
Pfizer deal paves way for approval of ImaginAb's cancer imaging tech
ImaginAb has signed a deal with Pfizer, which it hopes will help it …
News
Oxford BioTherapeutics to research cell therapies for Gilead’s Kite
Gilead Sciences’ Kite unit has teamed up with the UK’s Oxford …
Market Access
Makary: Drugs don’t have to take 10 years to get to market
FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply held assumptions”.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
